Announces Unsuccessful Phase 3 Trial for Blood Cancer Drug

tipranks.com/news/abbvie-abbv-announces-unsuccessful-phase-3-trial-for-blood-cancer-drug

Earlier today, drugmaker AbbVie ($ABBV) announced that its Phase 3 trial for a blood cancer treatment using venetoclax, which was developed with Ro...

This story appeared on tipranks.com, 2025-06-16 19:20:00.
The Entire Business World on a Single Page. Free to Use →